Biostar Pharmaceuticals Stock One Year Return
| BSPMDelisted Stock | USD 0.01 0.00 0.00% |
Biostar Pharmaceuticals fundamentals help investors to digest information that contributes to Biostar Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Biostar Pink Sheet. The fundamental analysis module provides a way to measure Biostar Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biostar Pharmaceuticals pink sheet.
Biostar |
Biostar Pharmaceuticals Company One Year Return Analysis
Biostar Pharmaceuticals' One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
CompetitionBased on the recorded statements, Biostar Pharmaceuticals has an One Year Return of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Pharmaceuticals, Biotechnology & Life Sciences (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Biostar One Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biostar Pharmaceuticals' direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biostar Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Biostar Pharmaceuticals by comparing valuation metrics of similar companies.Biostar Pharmaceuticals is currently under evaluation in one year return category among its peers.
Biostar Fundamentals
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 | ||||
| Profit Margin | 2.94 % | ||||
| Operating Margin | 8.76 % | ||||
| Current Valuation | 316.46 K | ||||
| Shares Outstanding | 2.64 M | ||||
| Number Of Shares Shorted | 170.44 K | ||||
| Price To Book | 0.01 X | ||||
| Price To Sales | 0.0001 X | ||||
| Revenue | 317.79 K | ||||
| Gross Profit | 915.17 K | ||||
| EBITDA | (1.7 M) | ||||
| Net Income | (5.7 M) | ||||
| Cash And Equivalents | 364.97 K | ||||
| Cash Per Share | 0.14 X | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 0.19 X | ||||
| Book Value Per Share | 13.71 X | ||||
| Cash Flow From Operations | 4.91 M | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | 0.06 X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 200 | ||||
| Beta | -2923.36 | ||||
| Market Capitalization | 94 | ||||
| Total Asset | 42.5 M | ||||
| Retained Earnings | 3.16 M | ||||
| Working Capital | 9.07 M | ||||
| Current Asset | 16.17 M | ||||
| Current Liabilities | 7.1 M | ||||
| Net Asset | 42.5 M |
About Biostar Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biostar Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biostar Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biostar Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |